selectION Therapeutics GmbH
2 clinical trials · Sponsor
◉ Watch selectION Therapeutics GmbH
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis (NCT06191042) | selectION Therapeutics GmbH | 2024-01-22 |
| A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis (NCT05383378) | selectION Therapeutics GmbH | 2022-08-30 |
Track selectION Therapeutics GmbH automatically
Every clearance here is in the API, with alerts when new ones post.